599 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Stomach Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing
Conditions: Colorectal Cancer;   Stomach Disease
Interventions: Other: FIT(Eiken OC-Sensor) Two-day sampling;   Other: FIT(Eiken OC-Sensor) One-year interval;   Other: FIT(Eiken OC-Sensor) One-day sampling;   Other: FIT(Eiken OC-Sensor) Two-year interval;   Other: HpSA (Firstep Helicobacter pylori Antigen Rapid Test)
2 Not yet recruiting A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy
Condition: NSAID-induced Gastropathy
Interventions: Drug: bismuth tripotassium dicitrate;   Drug: pantoprazole
3 Unknown  Diagnosis of Gastric Lesions With Na-nose
Condition: Stomach Diseases
Intervention:
4 Unknown  Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks
Conditions: Migraine Headache;   Gastric Diseases
Interventions: Drug: propranolol;   Drug: Quince's oxymel;   Drug: placebo
5 Unknown  Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm
Conditions: Disorder of Stomach Function and Feeding Problems in Newborn;   Feeding and Eating Disorders of Childhood
Interventions: Drug: Triple viable Bifidobacterium 0.5 bid po;   Dietary Supplement: early Micro-feeding
6 Unknown  Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
Conditions: Portal Hypertension Gastropathy;   Esophageal Varices;   Spontaneous Bacterial Peritonitis;   Hepatic Encephalopathy;   Ascites
Interventions: Drug: propranolol;   Drug: carvedilol;   Drug: placebo
7 Unknown  Cytokine Gene Polymorphisms in Gastric Diseases
Conditions: Gastric Ulcer;   Duodenal Ulcer;   Gastric Cancer
Intervention: Procedure: IL-1, TNF-alpha, Il-10
8 Recruiting Domperidone for Refractory Gastrointestinal Disorders
Condition: Gastroparesis
Intervention: Drug: Domperidone
9 Recruiting Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Interventions: Drug: Metoclopramide Nasal Spray;   Drug: Placebo Nasal Spray
10 Recruiting Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Interventions: Drug: Metoclopramide Nasal Spray;   Drug: Placebo Nasal Spray
11 Not yet recruiting The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using Immunohistochemistry
Condition: Gastric Cancer Surgical Specimens,18-80 Years Old, at Least Two Tumor Tissue Blocks
Intervention: Procedure: choose two tumor tissue paraffin blocks
12 Recruiting Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
Conditions: OGD;   Gastric Ulcer Induced by Anti-platelet Agent;   Duodenal Ulcer Induced by Anti-platelet Agent
Interventions: Procedure: Second-look OGD;   Drug: Esomeprazole
13 Recruiting CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
Conditions: Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Pancreatic Carcinoma;   Triple-Negative Invasive Breast Carcinoma;   Malignant Glioma of Brain;   Colorectal Carcinoma;   Gastric Carcinoma
Intervention: Biological: anti-MUC1 CAR-pNK cells
14 Recruiting Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Conditions: Non-small Cell Lung Cancer;   Esophageal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Hepatocellular Cancer;   Colorectal Cancer
Intervention: Other: Blood draws, urine and tissue asservation, bone marrow aspiration
15 Recruiting RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease
Conditions: Parkinson's Disease;   Gastroparesis;   Constipation
Interventions: Drug: RQ-00000010;   Drug: Placebo
16 Recruiting Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy
Condition: Stomach Neoplasms
Interventions: Procedure: Isoperistaltic;   Procedure: Antiperistaltic
17 Not yet recruiting Metabolic Consequences of Gastrointestinal Surgery
Conditions: Gastrectomy;   Oesophagectomy;   Dumping Syndrome;   Hypoglycaemia
Interventions: Drug: Somatostatin;   Drug: Rifaximin
18 Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
19 Not yet recruiting Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Conditions: Functional Pancreatic Neuroendocrine Tumor;   Malignant Somatostatinoma;   Merkel Cell Carcinoma;   Metastatic Adrenal Gland Pheochromocytoma;   Metastatic Carcinoid Tumor;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2A;   Multiple Endocrine Neoplasia Type 2B;   Neuroendocrine Neoplasm;   Non-Functional Pancreatic Neuroendocrine Tumor;   Pancreatic Glucagonoma;   Pancreatic Insulinoma;   Recurrent Adrenal Cortex Carcinoma;   Recurrent Adrenal Gland Pheochromocytoma;   Recurrent Merkel Cell Carcinoma;   Somatostatin-Producing Neuroendocrine Tumor;   Stage III Adrenal Cortex Carcinoma;   Stage III Thyroid Gland Medullary Carcinoma;   Stage IIIA Merkel Cell Carcinoma;   Stage IIIB Merkel Cell Carcinoma;   Stage IV Adrenal Cortex Carcinoma;   Stage IV Merkel Cell Carcinoma;   Stage IVA Thyroid Gland Medullary Carcinoma;   Stage IVB Thyroid Gland Medullary Carcinoma;   Stage IVC Thyroid Gland Medullary Carcinoma;   Thymic Carcinoid Tumor;   VIP-Producing Neuroendocrine Tumor;   Well Differentiated Adrenal Cortex Carcinoma;   Zollinger Ellison Syndrome
Interventions: Drug: Capecitabine;   Drug: Temozolomide;   Drug: Veliparib;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
20 Not yet recruiting Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
Condition: Gastritis Associated With Helicobacter Pylori
Interventions: Drug: vonoprazan 20 mg bid;   Drug: Amoxicillin 500 mg tid;   Drug: Amoxicillin 750 mg bid;   Drug: Clarithromycin 200 mg bid;   Drug: Metronidazole 250 mg bid

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years